Miltenyi Biomedicine Gmbh
Clinical trials sponsored by Miltenyi Biomedicine Gmbh, explained in plain language.
-
New immune cell therapy targets stubborn MS in early human trial
Disease control Not yet recruitingThis early-stage trial is testing a new treatment called MB-CART 2019.1 for people with multiple sclerosis (MS) that continues to get worse despite standard medications. The study will first check if the treatment is safe and find the right dose, then see if it can stop all signs…
Phase: PHASE1, PHASE2 • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated Mar 23, 2026 15:20 UTC
-
New transplant method offers hope for blood cancer patients without matched donors
Disease control Not yet recruitingThis small pilot study is testing a new method for stem cell transplants in adults with high-risk blood cancers who do not have a fully matched donor. It uses a special process to prepare stem cells from a half-matched (haploidentical) family donor, aiming to reduce the risk of a…
Phase: NA • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC